Open Access
Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
Author(s) -
Ikeda Yuki,
Ono Michihiro,
Ohmori Ginji,
Ameda Saki,
Yamada Michiko,
Abe Tomoyuki,
Fujii Shigeyuki,
Fujita Miri,
Maeda Masahiro
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4008
Subject(s) - pembrolizumab , medicine , microsatellite instability , intrahepatic cholangiocarcinoma , chemotherapy , oncology , gastroenterology , cancer , microsatellite , immunotherapy , gene , allele , biochemistry , chemistry
Key Clinical Message The tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.